Advances in Immunotherapy for Earlier Stages of Cancer: Guidance for Multidisciplinary Teams

Learn more about the recent advances in immunotherapy in earlier stages of cancer and gain expert insight on personalized approaches to prevent, mitigate, and manage the associated immune-related adverse events, featuring an on-demand webcast and downloadable slideset from a live workshop series.

Share

Program Content

Activities

ICIs in Early Cancer Stages
Advances in Immunotherapy for Earlier Stages of Cancer: Guidance for Community Multidisciplinary Teams
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 22, 2023

Activities

Immunotherapy for Early Cancer
Advances in Immunotherapy for Earlier Stages of Cancer: Guidance for Community Multidisciplinary Teams
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2023

Expires: July 23, 2024

Faculty

cover img faculity

Patrick Forde, MBBCh

Director, Thoracic Oncology Research Program
Oncology Department
Johns Hopkins University
Baltimore, Maryland

cover img faculity

Heather McArthur, MD, MPH

Associate Professor
Department of Internal Medicine
Clinical Director, Breast Cancer Program
Komen Distinguished Chair in Clinical Breast Cancer Research
UT Southwestern Medical Center
Dallas, Texas

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC